Literature DB >> 16082630

Validation of single-factor structure and scoring protocol for the Health Assessment Questionnaire-Disability Index.

Jason C Cole1, Sarosh J Motivala, Dinesh Khanna, Jessica Y Lee, Harold E Paulus, Michael R Irwin.   

Abstract

OBJECTIVE: The extensively used Health Assessment Questionnaire Disability Index (HAQ-DI) has been well received by the research and clinical community, notably because of its measurement strengths including reliability and stability of scores over time, utility in observational studies and clinical trials, predictive relationship with morbidity and mortality in rheumatoid arthritis (RA), and its translation for use in different countries. However, HAQ-DI scoring has not been validated. The purpose of this study was to examine the structural validity of the HAQ-DI and evaluate the latent factors underlying HAQ-DI scoring.
METHODS: This study used a cross-validation approach on a total of 278 patients with RA. Exploratory and confirmatory factor analyses were performed.
RESULTS: Results yielded a single-factor HAQ-DI score, which favored the current scoring system of the HAQ-DI. Additionally, modification indices suggested improved model fit with the secondary inclusion of correlated residual scores from a motor skills subdomain.
CONCLUSION: The current study provides the first validation of the HAQ-DI scoring system as determined by its latent factor structure. In addition, the findings suggest some benefit from a secondary interpretation of the scores based on domains that measure motor skills.

Entities:  

Mesh:

Year:  2005        PMID: 16082630     DOI: 10.1002/art.21325

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  11 in total

1.  2019 American College of Rheumatology Recommended Patient-Reported Functional Status Assessment Measures in Rheumatoid Arthritis.

Authors:  Claire E H Barber; JoAnn Zell; Jinoos Yazdany; Aileen M Davis; Laura Cappelli; Linda Ehrlich-Jones; Donna Everix; J Carter Thorne; Victoria Bohm; Lisa Suter; Alex Limanni; Kaleb Michaud
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-11-11       Impact factor: 4.794

2.  Single-factor scoring validation for the Health Assessment Questionnaire-Disability Index (HAQ-DI) in patients with systemic sclerosis and comparison with early rheumatoid arthritis patients.

Authors:  Jason C Cole; Dinesh Khanna; Philip J Clements; James R Seibold; Donald P Tashkin; Harold E Paulus; Michael R Irwin; Sarosh J Motivala; Daniel E Furst
Journal:  Qual Life Res       Date:  2006-07-07       Impact factor: 4.147

3.  Plasma glutathione peroxidase (GSH-Px) concentration is elevated in rheumatoid arthritis: a case-control study.

Authors:  Glenn A Jacobson; Stephen J Ives; Christian Narkowicz; Graeme Jones
Journal:  Clin Rheumatol       Date:  2012-07-28       Impact factor: 2.980

4.  Application of the health assessment questionnaire disability index to various rheumatic diseases.

Authors:  Maaike M van Groen; Peter M ten Klooster; Erik Taal; Mart A F J van de Laar; Cees A W Glas
Journal:  Qual Life Res       Date:  2010-06-18       Impact factor: 4.147

5.  Psychometric properties of the Chinese Version of the Readiness for Hospital Discharge Scale for people living with HIV.

Authors:  Chen Chen; Xiaoxia Zhang; Chulei Tang; Xueling Xiao; Zirong Tao; Honghong Wang
Journal:  Int J Nurs Sci       Date:  2019-12-28

6.  Measuring illness behavior in patients with systemic sclerosis.

Authors:  Erin L Merz; Vanessa L Malcarne; Scott C Roesch; Roozbeh Sharif; Brock E Harper; Hilda T Draeger; Emilio B Gonzalez; Deepthi K Nair; Terry A McNearney; Shervin Assassi; Maureen D Mayes
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-04       Impact factor: 4.794

Review 7.  Challenges comparing functional limitations in rheumatoid arthritis and ankylosing spondylitis.

Authors:  G H Louie; J D Reveille; M M Ward
Journal:  Clin Exp Rheumatol       Date:  2009 Jul-Aug       Impact factor: 4.473

Review 8.  Comparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs--a systematic review and network meta-analysis.

Authors:  Jeroen P Jansen; Felicity Buckley; Fred Dejonckheere; Sarika Ogale
Journal:  Health Qual Life Outcomes       Date:  2014-07-03       Impact factor: 3.186

9.  Rapid and sustained improvements in health-related quality of life, fatigue, and other patient-reported outcomes in rheumatoid arthritis patients treated with certolizumab pegol plus methotrexate over 1 year: results from the RAPID 1 randomized controlled trial.

Authors:  Vibeke Strand; Philip Mease; Gerd R Burmester; Enkeleida Nikaï; Geoffroy Coteur; Ronald van Vollenhoven; Bernard Combe; Edward C Keystone; Arthur Kavanaugh
Journal:  Arthritis Res Ther       Date:  2009-11-12       Impact factor: 5.156

10.  Survey of a community-based infusion program for Australian patients with rheumatoid arthritis requiring treatment with tocilizumab: patient characteristics and drivers of patient satisfaction and patient-perceived benefits and concerns.

Authors:  Louisa Voight
Journal:  Patient Prefer Adherence       Date:  2012-04-10       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.